Quick Answer
SINOVAC BIOTECH LTD reported Earnings Per Share Diluted of $1.06 (loss) per share for the year ending 2023.
- SINOVAC BIOTECH LTD showed a decrease of -206.0% in Earnings Per Share Diluted from 2022 to 2023.
- This data is from SINOVAC BIOTECH LTD's annual report (Form 10-K), filed with the SEC on April 29, 2024.
- XBRL data for this metric is available from 2009 to 2023 (14 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
- Over the full 14 years of available data (2009 to 2023), SINOVAC BIOTECH LTD's Earnings Per Share Diluted has declined by 330.4%.
- Historical annual values: Fiscal year 2023: $1.06 (loss) per share | Fiscal year 2022: $1.00 per share | Fiscal year 2021: $74.27 per share | Fiscal year 2020: $0.97 per share | Fiscal year 2019: $0.41 per share | Fiscal year 2018: $0.34 per share | Fiscal year 2017: $0.45 per share | Fiscal year 2016: $0.01 (loss) per share | Fiscal year 2015: $0.03 (loss) per share | Fiscal year 2014: $0.03 (loss) per share | Fiscal year 2013: $0.13 per share | Fiscal year 2011: $0.02 (loss) per share | Fiscal year 2010: $0.16 (loss) per share | Fiscal year 2009: $0.46 per share.
- Data sourced from SEC EDGAR public filings as of June 21, 2026.
Last verified: